- Home
- TBPH vs SWIM Comparison
TBPH vs SWIM Comparison
Compare TBPH & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBPH | SWIM |
|---|---|---|
| Founded | 2013 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 908.9M | 838.8M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TBPH | SWIM |
|---|---|---|
| Price | $17.03 | $7.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $18.40 | $6.75 |
| AVG Volume (30 Days) | 377.6K | ★ 911.2K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 279.13 | 160.00 |
| EPS | N/A | ★ 0.04 |
| Revenue | $15,386,000.00 | ★ $545,912,000.00 |
| Revenue This Year | $8.46 | $10.95 |
| Revenue Next Year | N/A | $6.34 |
| P/E Ratio | ★ N/A | $175.75 |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $13.08 | $4.64 |
| 52 Week High | $21.03 | $8.97 |
Technical Indicators
Market Signals| Indicator | TBPH | SWIM |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 56.44 |
| Support Level | $16.80 | $6.13 |
| Resistance Level | $17.17 | $7.33 |
| Average True Range (ATR) | 0.05 | 0.35 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 93.75 | 43.30 |
Price Performance
Historical ComparisonAbout TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
About SWIM Latham Group Inc.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. The company derives a majority of its revenue from the United States.